The real deal: how pharma counsel spot counterfeit drugs
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings

The real deal: how pharma counsel spot counterfeit drugs

Rani Mehta
May 20, 2022
counterfeitpharmacover.jpg

Pharma counsel can look at suspicious packaging, online sellers and other signs to learn whether products are fake, say sources at Merck, Gilead and Organon

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

TrademarksIP StrategyUnited StatesNewsNorth AmericaLife sciencesCounterfeiting and e-commerce
rani-mehta-300px.png
Rani Mehta
Senior Reporter Managing IP
Contact
Rani reports on all aspects of IP in the US and the Americas, particularly trademarks and copyright. Based in New York, she covers in-house and private practice lawyers' concerns and insights into the market.
more from across site and ros bottom lb

More from across our site

MIP+ WcW 680x383 CSR@2x.png
What Corporates Want: corporate social responsibility
A majority of clients – particularly high-earning businesses – want advisers with demonstrable social credentials, according to a survey of more than 28,000 corporate counsel
Sukanya Sarkar, May 10, 2024
Copyright
View of marble columns and greek classical architecture of the U
Copyright plaintiffs hoping for big wins after SCOTUS ruling
The US Supreme Court’s ruling in Warner Chappell Music v Nealy is a boost for certain copyright plaintiffs, but some counsel wonder if the court addressed the right question
Rani Mehta, May 10, 2024
Patents
Leading.jpg
Qantm backs private equity firm’s buyout bid
Private equity firm Adamantem Capital leads the race to acquire Australia-based intellectual property business Qantm IP
Sukanya Sarkar, May 10, 2024
Patents
adobestock-272742878.jpeg
This week on MIP: IPH proposes Qantm buyout, Tesla trademark row
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Max Walters, May 10, 2024
Patents
The inscription Pro bono on the plate in the form of scales.
How firms help IP associates with pro bono work
Counsel at four firms reveal how they supervise associates on pro bono matters and what kind of volunteer work their attorneys do
Rani Mehta, May 10, 2024
Patents
Kobialka_Frankel_combined.jpg
Behind the case: Duty calls for Kramer Levin in $23m patent win
Kramer Levin litigators explain how they secured victory for their client against Microsoft subsidiary Activision in a dispute concerning the video game ‘Call of Duty’
Rani Mehta, May 09, 2024
Trademarks
Brand Action (1).png
Time or action: how IP firms can help support people in crisis
Steven Cooper, partner at Ware Fressola Maguire & Barber, explains what sponsoring Brand Action means for his firm and why the IP community is well-placed to help
Steven Cooper, May 09, 2024
Patents
csm_tilman-mueller-stoy-bardehle-pagenberg-0873_eeb5b1f531.jpg
Five mins with… Tilman Müller-Stoy, Bardehle Pagenberg
Tilman Müller-Stoy reveals why he never made it as a footballer and how he could have had an alternative career as a fire juggler
May 09, 2024
Patents
A Vintage computer in a dimly lit room with red illumination reading "error"
Weekly take: UPC must eliminate distractions to truly flourish
As the UPC approaches its first anniversary, there’s a risk that persisting teething issues will continue to be the major pain points
Max Walters, May 09, 2024
Copyright
Generative AI.jpeg
AI copyright infringement: a PRC court’s missed opportunity to set the law
Justin Davidson and Stanley Ng of Norton Rose Fulbright discuss what China’s recent Ultraman ruling does and doesn’t say about who is responsible when an AI system infringes copyright
Justin Davidson, May 08, 2024
Gift this article